Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control

被引:117
作者
Gould, I. M. [1 ]
机构
[1] Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen AB25 2ZN, Scotland
关键词
hospital-acquired MRSA; costs;
D O I
10.1016/j.ijantimicag.2006.09.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
For most countries badly affected by methicillin-resistant Staphylococcus aureus (MRSA) there have been many years of debate about its relative virulence compared with methicillin-susceptible S. aureus (MSSA) and whether it could be controlled. Now that it is endemic in the majority of hospitals around the world, it is clear that it is at least as virulent as MSSA and is an additional burden of healthcare-acquired infection. There is increasing evidence that, despite this endemicity, control efforts can be successful, although they are often perceived as expensive. In reality, there is a large body of consistent evidence that control is highly cost effective, particularly in the context of the huge societal costs of MRSA and the future ever-greater threats that it poses. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 61 条
[1]   Nosocomial methicillin-resistant and methicillin-susceptible, Staphylococcus aureus primary bacteremia:: At what costs [J].
Abramson, MA ;
Sexton, DJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06) :408-411
[2]  
[Anonymous], 2004, CDR WEEKLY, V14, P1
[3]  
[Anonymous], PROVISION ALCOHOL BA
[4]   Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital [J].
Björholt, I ;
Haglind, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (09) :688-695
[5]   CONTROL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS BACTEREMIA IN HIGH-RISK AREAS [J].
BLUMBERG, LH ;
KLUGMAN, KP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (01) :82-85
[6]   Controlling methicillin-resistant Staphylococcus aureus:: Quantifying the effects of interventions and rapid diagnostic testing [J].
Bootsma, MCJ ;
Diekmann, O ;
Bonten, MJM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5620-5625
[7]   Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus:: Evidence of resistance to vancomycin [J].
Burnie, J ;
Matthews, R ;
Jiman-Fatami, A ;
Gottardello, P ;
Hodgetts, S ;
D'arcy, S .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (03) :684-689
[8]   A model to compute the medical cost of patients in intensive care [J].
Chaix, C ;
Durand-Zaleski, I ;
Alberti, C ;
Brun-Buisson, C .
PHARMACOECONOMICS, 1999, 15 (06) :573-582
[9]   Control of endemic methicillin-resistant Staphylococcus aureus -: A cost-benefit analysis in an intensive care unit [J].
Chaix, C ;
Durand-Zaleski, I ;
Alberti, C ;
Brun-Buisson, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18) :1745-1751
[10]   Methicillin-resistant Staphylococcus aureus in hospitals and the community:: Stealth dynamics and control catastrophes [J].
Cooper, BS ;
Medley, GF ;
Stone, SP ;
Kibbler, CC ;
Cookson, BD ;
Roberts, JA ;
Duckworth, G ;
Lai, R ;
Ebrahim, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (27) :10223-10228